Switzerland Blood And Blood Forming Organs Medicine Sales is set to reach $540.7 Million by 2026 from $457.2 Million 2021, was up 7.1% per year. Since 2017, the market jumped by 6.1% year on year totalising $27,250 Million. The country came in number 12 in 2021, Sweden overtook $457.2 Million. Germany, Italy and South Korea respectively came in numbers 2, 3 and 4 in this ranking.
How does Switzerland rank in Blood and Blood Forming Organs Medicine Sales?
| # | 13 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 7,630 | 2023 | +9.89% | +11.95% | View data |
| 2 | 2 Spain | 2,310 | 2023 | +4.73% | +3.57% | View data |
| 3 | 3 Austria | 532.1 | 2023 | +6.31% | +6.1% | View data |
| 4 | 4 Switzerland | 515.7 | 2023 | +8.23% | +5.44% | |
| 5 | 5 Finland | 388.2 | 2023 | +5.12% | +6.68% | View data |
| 6 | 6 Portugal | 321.8 | 2023 | +0.85% | +3.87% | View data |